A detailed history of Destination Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Destination Wealth Management holds 703,928 shares of PFE stock, worth $18.8 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
703,928
Previous 665,021 5.85%
Holding current value
$18.8 Million
Previous $18.6 Million 9.48%
% of portfolio
0.64%
Previous 0.62%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 25, 2024

BUY
$27.7 - $31.39 $1.08 Million - $1.22 Million
38,907 Added 5.85%
703,928 $20.4 Million
Q2 2024

Jul 24, 2024

BUY
$25.26 - $29.6 $865,786 - $1.01 Million
34,275 Added 5.43%
665,021 $18.6 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $2.8 Million - $3.21 Million
108,068 Added 20.68%
630,746 $17.5 Million
Q4 2023

Feb 13, 2024

SELL
$26.13 - $33.94 $2.06 Million - $2.67 Million
-78,657 Reduced 13.08%
522,678 $15 Million
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $732,165 - $855,828
22,816 Added 3.94%
601,335 $19.9 Million
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $445,215 - $515,103
12,326 Added 2.18%
578,519 $21.2 Million
Q1 2023

May 05, 2023

BUY
$39.39 - $51.28 $480,833 - $625,974
12,207 Added 2.2%
566,193 $23.1 Million
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $526,425 - $687,190
-12,609 Reduced 2.23%
553,986 $28.4 Million
Q3 2022

Nov 10, 2022

SELL
$43.76 - $53.42 $75,617 - $92,309
-1,728 Reduced 0.3%
566,595 $24.8 Million
Q2 2022

Jul 29, 2022

SELL
$46.53 - $55.17 $243,770 - $289,035
-5,239 Reduced 0.91%
568,323 $29.8 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $428,540 - $531,015
-9,367 Reduced 1.61%
573,562 $29.7 Million
Q4 2021

Feb 04, 2022

SELL
$41.32 - $61.25 $9,007 - $13,352
-218 Reduced 0.04%
582,929 $34.4 Million
Q3 2021

Oct 25, 2021

SELL
$39.25 - $50.42 $22,843 - $29,344
-582 Reduced 0.1%
583,147 $25.1 Million
Q2 2021

Aug 13, 2021

BUY
$35.91 - $40.68 $596,213 - $675,410
16,603 Added 2.93%
583,729 $22.9 Million
Q1 2021

May 05, 2021

BUY
$33.49 - $37.77 $1.08 Million - $1.22 Million
32,374 Added 6.05%
567,126 $20.5 Million
Q4 2020

Feb 11, 2021

BUY
$33.47 - $42.56 $207,547 - $263,914
6,201 Added 1.17%
534,752 $19.7 Million
Q3 2020

Nov 12, 2020

BUY
$31.75 - $37.25 $198,437 - $232,812
6,250 Added 1.2%
528,551 $19.4 Million
Q2 2020

Aug 14, 2020

BUY
$30.12 - $36.54 $232,195 - $281,686
7,709 Added 1.5%
522,301 $17.1 Million
Q1 2020

May 13, 2020

BUY
$27.03 - $38.62 $211,104 - $301,622
7,810 Added 1.54%
514,592 $16.8 Million
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $515,296 - $584,796
15,653 Added 3.19%
506,782 $19.9 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $796,654 - $1.03 Million
24,520 Added 5.25%
491,129 $17.6 Million
Q2 2019

Jul 19, 2019

SELL
$36.98 - $41.52 $285,966 - $321,074
-7,733 Reduced 1.63%
466,609 $20.2 Million
Q1 2019

May 01, 2019

SELL
$37.5 - $41.2 $615,300 - $676,009
-16,408 Reduced 3.34%
474,342 $20.1 Million
Q4 2018

Feb 05, 2019

SELL
$38.47 - $43.86 $459,024 - $523,337
-11,932 Reduced 2.37%
490,750 $21.4 Million
Q3 2018

Nov 07, 2018

BUY
$34.47 - $41.81 $70,422 - $85,417
2,043 Added 0.41%
502,682 $22.2 Million
Q2 2018

Jul 31, 2018

BUY
$32.98 - $35.16 $16.5 Million - $17.6 Million
500,587 Added 962667.31%
500,639 $18.2 Million
Q1 2018

Apr 05, 2018

SELL
$31.91 - $37.02 $4.73 Million - $5.49 Million
-148,190 Reduced 99.96%
52 $1,000
Q4 2017

Feb 09, 2018

BUY
$33.26 - $35.29 $76,730 - $81,414
2,307 Added 1.58%
148,242 $5.37 Million
Q3 2017

Nov 09, 2017

BUY
$31.0 - $34.15 $3,410 - $3,756
110 Added 0.08%
145,935 $5.21 Million
Q2 2017

Aug 11, 2017

BUY
N/A
145,825
145,825 $4.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Destination Wealth Management Portfolio

Follow Destination Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.